anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 70,681-70,710
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

70,681-70,710 of 110,355

filter-aware
17
The slide uses a before-after framework to illustrate the physiological impact of the drug.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
20
The chart is a forest plot showing LS Mean differences with 95% confidence intervals for various OHQ questionnaire scores.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
21
The slide outlines a clinical trial methodology using a randomized withdrawal design.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
22
The slide uses a combination of market sizing metrics and a competitive product comparison table.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
25
Includes per share data and share counts for basic and diluted calculations.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
28
The chart shows a significant reduction in operating expenses from 2020 to 2023 guidance.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
31
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
32
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
35
The slide uses a mathematical formula structure to explain revenue recognition.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
36
The table displays projected royalties and milestones for 2023-2026, while the right side details royalty return dates for 2029 and 2031.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
38
Uses a funnel diagram to illustrate market penetration.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
40
The slide contrasts a narrow 'dizziness' focus with a broader 'constellation of symptoms' approach for MSA patients.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
41
The slide uses a three-column layout to categorize achievements into product, clinical, and financial pillars.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
05
The slide uses a waterfall bridge to reconcile equity adjustments between two entities.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
07
The slide provides a breakdown of mark-downs and mark-ups for various asset classes, including loans, real estate, and software, following IFRS 3 acquisition rules.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
09
The chart bridges Credit Suisse equity to pro forma negative goodwill via transaction adjustments.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
05
The slide uses a process-flow visual to connect three key financial metrics.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
06
2020 data is omitted due to COVID-19 pandemic.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
The slide includes a footnote defining Marketplace GOV.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
09
Includes margin percentages overlaid on bar charts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
11
The slide uses a hub-and-spoke diagram to center 'Strategic Flexibility' as the outcome of four financial pillars.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Financials1 hit
16
The slide explains the dual-class structure and how it relates to financial reporting and economic interest.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
18
The chart includes a trend line showing a 3-4% CAGR over the period.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
05
Data source: China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide highlights improvements in skincare revenue, gross margin, S&M expense efficiency, and a shift to GAAP profitability.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
Includes revenue from DR.WU (mainland China), Galénic, Eve Lom, Abby's Choice, and others.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · So What Cascade1 hit
09
The slide highlights a 59% YoY growth in combined net revenues for the three brands.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · So What Cascade1 hit
12
Data shows a decline in revenue but an improvement in gross margin.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
13
The slide explains the drivers behind the reduction in G&A and S&M expenses, specifically citing share-based compensation reversals and store closures.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
15
The chart displays quarterly operating cashflow as bars and the total cash balance as oval-enclosed numbers above the bars.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit